检索结果-南通市图书馆

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline(updated version)

在线全文

学校读者我要写书评

暂无评论

Military Medical Research 2020年第3期7卷 249-282页

作者： ying-Hui Jin qing-Yuan Zhan Zhi-yong Peng xue-Qun Ren Xun-Tao Yin Lin Cai Yu-Feng Yuan Ji-Rong Yue Xiao-Chun Zhang Qi-Wen Yang Jianguang Ji Jian Xia Yi-Rong Li Fu-Xiang Zhou Ya-Dong Gao Zhui Yu Feng Xu Ming-Li Tu Li-Ming Tan Min Yang Fang Chen Xiao-Ju Zhang Mei Zeng Yu Zhu Xin-Can Liu Jian Yang Dong-Chi Zhao Yu-Feng ding Ning Hou Fu-Bing Wang Hao Chen yong-Gang Zhang Wei Li Wen Chen Yue-Xian Shi Xiu-Zhi Yang xue-Jun Wang Yan-Jun Zhong Ming-Juan Zhao Bing-Hui Li Lin-lu Ma Hao Zi Na Wang Yun-Yun Wang Shao-Fu Yu lu-Yao Li Qiao Huang Hong Weng Xiang-ying Ren Li-Sha luo Man-Ru Fan Di Huang Hong-Yang xue Lin-Xin Yu Jin-Ping Gao Tong Deng Xian-Tao Zeng Hong-Jun Li zhen-Shun Cheng Xiao-Mei Yao Xing-Huan Wang Center for Evidence-Based and Translational Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China National Clinical Research Center for Respiratory Diseases China-Japan Friendship HospitalBeijing 100029China Department of Pulmonary and Critical Care Medicine China-Japan Friendship HospitalBeijing 10029China Leishenshan Hospital in Wuhan Wuhan 430200China Department of Critical Care Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China Institutes of Evidence-based Medicine and Knowledge Translation Henan UniversityKaifeng 475000HenanChina Department of Medical Imaging Guizhou Provincial People’s HospitalGuiyang 550002China Departments of Orthopedics Zhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Hepatobiliary Surgery Zhongnan Hospital of Wuhan UniversityWuhan 430071China National Clinical Research Center for Geriatrics West China Hospital of Sichuan UniversityChengdu 610041China Department of Geriatrics West China Hospital of Sichuan UniversityChengdu 610041China Department of Radiology Zhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Clinical Laboratory Peking Union Medical College Hospital(PUMCH)Peking Union Medical CollegeChinese Academy of Medical Sciences(CAMS)Beijing 100730China Center for Primary Health Care Research Lund University and Region Skåne25002 MalmöSweden Emergency Center Zhongnan Hospital of Wuhan UniversityWuhan 403371China Department of Allergology Zhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Radiation and Medical Oncology Zhongnan Hospital of Wuhan UniversityWuhan 43071China Department of Critical Care Medicine Renmin Hospital of Wuhan UniversityWuhan 430060China Department of Emergency Medicine and Chest Pain Center Qilu Hospital of Shandong UniversityJinan 250002China Department of Respiratory and Critical Care Medicine Suizhou Central HospitalHubei University of MedicineSuizhou 441300HubeiChina Department of Clinic Pharmacy Second People’s Hospital of Huaihua Ci

The novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is the cause of a rapidly spreading illness,coronavirus disease 2019(COVID-19),affecting more than seventeen million people around the *** and treatment guidelines for clinicians caring for patients are *** the early stage,we have issued"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus(2019-nCoV)infected pneumonia(standard version)";now there are many direct evidences emerged and may change some of previous recommendations and it is ripe for develop an evidence-based *** formed a working group of clinical experts and *** steering group members proposed 29 questions that are relevant to the management of COVID-19 covering the following areas:chemoprophylaxis,diagnosis,treatments,and discharge *** searched the literature for direct evidence on the management of COVID-19,and assessed its certainty generated recommendations using the Grading of Recommendations,Assessment,Development and Evaluation(GRADE)*** were either strong or weak,or in the form of ungraded consensus-based ***,we issued 34 *** them,6 were strong recommendations for,14 were weak recommendations for,3 were weak recommendations against and 11 were ungraded consensus-based *** covered topics of chemoprophylaxis(including agents and Traditional Chinese Medicine(TCM)agents),diagnosis(including clinical manifestations,reverse transcription-polymerase chain reaction(RT-PCR),respiratory tract specimens,IgM and IgG antibody tests,chest computed tomography,chest X-ray,and CT features of asymptomatic infections),treatments(including lopinavirritonavir,umifenovir,favipiravir,interferon,remdesivir,combination of antiviral drugs,hydroxychloroquine/chloroquine,interleukin-6 inhibitors,interleukin-1 inhibitors,glucocorticoid,qingfei paidu decoction,lianhua qingwen granules/capsules,convalescent plasma,lung

关键词： COVID-19 SARS-CoV-2 Recommendation Chemoprophylaxis Diagnosis Treatment Discharge management Traditional Chinese medicine guideline

The Lyman-alpha Solar Telescope(LST) for the ASO-S mission——Ⅱ. design of LST

在线全文

学校读者我要写书评

暂无评论

Research in Astronomy and Astrophysics 2019年第11期19卷 33-48页

作者： Bo Chen Hui Li Ke-Fei Song Quan-Feng Guo Pei-Jie Zhang Ling-Ping He Shuang Dai Xiao-Dong Wang Hai-Feng Wang Chun-Long Liu Hong-Ji Zhang Guang Zhang Yunqi Wang Shi-Jie Liu Hong-Xin Zhang Lei Liu Shi-Lei Mao Yang Liu Jia-Hao Peng Peng Wang Liang Sun Yang Liu zhen-Wei Han Yan-Long Wang Kun Wu Guang-Xing ding Peng Zhou Xin zheng Ming-Yi Xia qing-Wen Wu Jin-Jiang Xie Ya Chen Shu-Mei Song Hong Wang Bo Zhu Chang-Bo Chu Wen-Gang Yang Li Feng Yu Huang Wei-Qun Gan ying Li Jing-Wei Li Lei lu Jian-Chao xue Bei-Li ying Ming-Zhe Sun Cheng Zhu Wei-Min Bao Lei Deng Zeng-shan Yin Changchun Institute of Optics FineMechanics and PhysicsChinese Academy of SciencesChangchun 130033China State Key Laboratory of Applied Optics Changchun 130033China Key Laboratory of Dark Matter and Space Astronomy Purple Mountain ObservatoryChinese Academy of SciencesNanjing 210034China School of Astronomy and Space Science University of Science and Technology of ChinaHefei 230026China Xi’an Institute of Optics and Precision Mechanics Chinese Academy of SciencesXi’an 710119China shandong University Weihai 264209China Innovation Academy for Microsatellites Chinese Academy of SciencesShanghai 201210China

As one of the three payloads for the Advanced Space-based Solar Observatory(ASO-S)mission,the Lyman-alpha(Lyα)Solar Telescope(LST)is composed of three instruments:a Solar Corona Imager(SCI),a LyαSolar Disk Imager(SDI)and a full-disk White-light Solar Telescope(WST).When working in-orbit,LST will simultaneously perform high-resolution imaging observations of all regions from the solar disk to the inner corona up to 2.5 R⊙(R⊙stands for the mean solar radius)with a spatial resolution of 4.8′′and 1.2′′for coronal and disk observations,respectively,and a temporal resolution of 30–120 s and 1–120 s for coronal and disk observations,*** maximum exposure time can be up to20 s due to precise pointing and image stabilization *** the three telescopes of LST,SCI is a dual-waveband coronagraph simultaneously and independently observing the inner corona in the HI Lyα(121.6±10 nm)line and white light(WL)(700±40 nm)wavebands by using a narrowband Lyαbeam splitter and has a field of view(FOV)from 1.1 to 2.5 R⊙.The stray-light suppression level can attain<10^-6 B⊙(B⊙is the mean brightness of the solar disk)at 1.1 R⊙and≤5×10^-8 B⊙at 2.5 R⊙.SDI and WST are solar disk imagers working in the Lyαline and 360.0 nm wavebands,respectively,which adopt an off-axis two-mirror reflective structure with an FOV up to 1.2 R⊙,covering the inner coronal edge area and relating to coronal *** present the up-to-date design for the LST payload.

关键词： telescopes—instrumentation high angular resolution—Sun flares—Sun coronal mass ejections(CMEs)—Sun UV radiation

Embryonic stem cells generated by nuclear transfer of human somatic nuclei into rabbit oocytes

在线全文

学校读者我要写书评

暂无评论

Cell Research 2003年第4期13卷 251-263页

作者： ying CHEN, ZHI Xu HE, AILIAN LIU, KAI WANG, WEN WEI MAO, JIAN XIN CHU, yong lu, zhenG Fu FANG, ying TANG SHI, qing ZHANG YANG, DA YUAN CHEN, MIN RANG WANG, JIN SONG LI, SHAO LIANG HUANG, XIANG YIN KONG, YAO ZHOU SHI, Zm QIANG WANG, JIA HuI XIA, ZHI GAO LONG, ZHI GANG xue, WEN XIANG ding, HuI zhen SHENG Center for Developmental Biology, shanghai Second Medical University, shanghai 200092, China Laboratory of Stem Cell Biology, Institute of Biochemistry and Cell Biology, shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 1665 Kong Jiang Road, shanghai 200092, China Center for Stem Cell Research, the Second Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510120,China State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, 19 Zhong-guan Cun Road, Haidian District, Beijing 100080, China Health Science Center, shanghai Institutes of Biological Sciences, Chinese Academy of Sciences and shanghai Second Medical University, shanghai 200025, China National Laboratory of Medical Genetics, Central South University, 88 Xiangya Road, Changsha 410078, China Xinhua Hospital, shanghai Second Medical University, 1665 Kong Jiang Road, shanghai 200092, China Center for Developmental Biology Shanghai Second Medical University Shanghai 200092 China Laboratory of Stem Cell Biology Institute of Biochemistry and Cell Biology Shanghai Institutes for Biological Sciences Chinese Academy of Sciences 1665 Kong Jiang Road Shanghai 200092 China Center for Stem Cell Research the Second Affiliated Hospital Sun Yat-Sen University Guangzhou 510120 China State Key Laboratory of Reproductive Biology Institute of Zoology Chinese Academy of Sciences 19 Zhong-guan Cun Road Haidian District Beijing 100080 China Health Science Center Shanghai Institutes of Biological Sciences Chinese Academy of Sciences and Shanghai Second Medical University Shanghai 200025 China National Laboratory of Medical Genetics Central South University 88 Xiangya Road Changsha 410078 China Xinhua Hospital Shanghai Second Medical University 1665 Kong Jiang Road Shanghai 200092 China

To solve the problem of immune incompatibility, nuclear transplantation has been envisaged as a means to produce cells or tissues for human autologous transplantation. Here we have derived embryonic stem cells by the transfer of human somatic nuclei into rabbit oocytes. The number of blastocysts that developed from the fused nuclear transfer was comparable among nuclear donors at ages of 5, 42, 52 and 60 years, and nuclear transfer (NT) embryonic stem cells (ntES cells) were subsequently derived from each of the four age groups. These results suggest that human somatic nuclei can form ntES cells independent of the age of the donor. The derived ntES cells are human based on karyotype, isogenicity, in situ hybridization, PCR and immunocytochemistry with probes that distinguish between the various species. The ntES cells maintain the capability of sustained growth in an undifferentiated state, and form embryoid bodies, which, on further induction, give rise to cell types such as neuron and muscle, as well

关键词： nuclear transfer (NT) somatic cell nuclear transfer (SCNT) embryonic stem cells (ES cell) therapeutic cloning rabbit oocyte.

Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

Chinese Medical Journal 2013年第12期126卷 2276-2280页

作者： zhenG ying CAI Guang-yan CHEN Xiang-mei FU Ping CHEN Jiang-hua ding Xiao-qiang YU xue-qing LIN Hong-li LIU Jian XIE Ru-juan WANG Li-ning NI Zhao-hui LIU Fu-you YIN Ai-ping XING Chang-ying WANG Li SHI Wei LIU Jian-she HE Ya-ni ding Guo-hua LI Wen-ge WU Guang-li MIAO Li-ning CHEN Nan SU zhen MEI Chang-lin ZHAO Jiu-yang GU yong BAI Yun-kai luO Hui-min LIN shan CHEN Meng-hua GONG Li YANG Yi-bin YANG Xiao-ping LI ying WAN Jian-xin WANG Nian-song LI Hai-ying XI Chun-sheng HAO Li XU Yan FANG Jing-ai LIU Bi-cheng LI Rong-shan WANG Rong ZHANG Jing-hong WANG Jian-qin LOU Tan-qi SHAO Feng-min MEI Feng LIU Zhi-hong YUAN Wei-jie SUN Shi-ren ZHANG Ling ZHOU Chun-hua CHEN Qin-kai JIA Shun-lian GONG Zhi-feng GUAN Guang-ju XIA Tian ZHONG Liang-bao Department of Nephrology State key Laboratory of Kidney Disease Chinese PLA General Hospital Beijing 100853 China Nephrology Institute of the Chinese People's Liberation Army Chinese People's Liberation Army Key Laboratory of Nephrology Beijing 100853 China Department of Nephrology West China Hospital of Sichuan University Chengdu Sichuan 610041 China Department of Nephrology First Affiliated Hospital School of Medicine Zhejiang University Hangzhou Zhejiang 310003 China Department of Nephrology Zhongshan Hospital Fudan University Shanghai 200032 China Department of Nephrology First Affiiated Hospital of Sun Yat-sen University Guangzhou Guangdong 510080 China Department of Nephrology First Affiliated Hospital of Dalian Medical University Dalian Liaoning 116011 China Department of Nephrology First Affiliated Hospital of Xinjiang Medical University Urumqi Xinjiang 830054 China Department of Nephrology First Affiliated Hospital of Harbin Medical University Harbin Heilongjiang 150001 China Department of Nephrology First Afftiated Hospital of China Medical University Shenyang Liaoning 110001 China Department of Nephrology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200025 China Department of Nephrology Second Xiangya Hospital Central South University Changsha Hunan 410000 China Department of Nephrology First Affiliated Hospital of Medical College Xi'an Jiaotong University Xi'an Shaanxi 710061 China Department of Nephrology First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital) Nanjing Jiangsu 210029 China Department of Nephrology Sichuan Provincial People's Hospital Chengdu Sichuan 610072 China Department of Nephrology Guangdong Provincial People's Hospital Guangzhou Guangdong 510030 China Department of Nephrology Affliated Xiehe Hospital Tongji Medical College Huazhong Science and Technology University Wuhan Hubei 430022 China Department of Nephrology Daping Hospital Third Military Medi

Background Data on the epidemiology of hypertension in Chinese non-dialysis chronic kidney disease （CKD） patients are *** aim of the present study was to investigate the prevalence,awareness,treatment,and control of hypertension in the non-dialysis CKD patients through a nationwide,multicenter study in *** The survey was performed in 61 tertiary hospitals in 31 provinces,municipalities,and autonomous regions in China （except Hong Kong,Macao,and Taiwan）.Trained physicians collected demographic and clinical data and measured blood pressure （BP） using a standardized *** was defned as systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg,and/or use of antihypertensive *** 〈140/90 mmHg and 〈130/80 mmHg were used as the 2 thresholds of hypertension *** multivariate logistic regression with adjustment for sex and age,we analyzed the association between CKD stages and uncontrolled hypertension in non-dialysis CKD *** The analysis included 8927 non-dialysis CKD *** prevalence,awareness,and treatment of hypertension in non-dialysis CKD patients were 67.3%,85.8%,and 81.0%,*** hypertensive CKD patients,33.1% and 14.1% had controlled BP to 〈140/90 mmHg and 〈130/80 mmHg,*** successive CKD stages,the prevalence of hypertension in non-dialysis CKD patients increased,but the control of hypertension decreased （P〈0.001）.When the threshold of BP 〈130/80 mmHg was considered,the risk of uncontrolled hypertension in CKD 2,3a,3b,4,and 5 stages increased 1.3,1.4,1.4,2.5,and 4.0 times compared with CKD 1 stage,respectively （P〈0.05）.Using the threshold of 〈140/90 mmHg,the risk of uncontrolled hypertension increased in advanced stages （P〈0.05）.Conclusions The prevalence of hypertension Chinese non-dialysis CKD patients was high,and the hypertension control was *** successive CKD stages,the risk of uncontrolled hypertension increased.

关键词： non-dialysis chronic kidney disease chronic kidney disease stages hypertension epidemiology

Consensus statement on layout and delivery of automatic external defibrillator in China

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Journal of Hainan Medical University 2020年第15期26卷 18-23页

作者： Yu Cao Song Chen Yan-Fen Chai Xiao-Hui Chen Yu-Guo Chen Shao-Wen Cheng Wen-Wei Cheng Bang-Han ding Yang Deng Jie Fu Bang-Jiang Fang Mai-ying Fan Li Gui Ping Gong Wei Guo Shu-Bin Guo Liang Huang Ji-Yuan Han Zhong Ji Xian-Fei Ji Xin-Cai Ji Hong-Xu Jin Xin-Jun Jiang Wang-Xiang Jiang Jia-Liang Liu Xiao-Ran Liu Zhi Liu Chuan-Zhu Lv Feng lu Tan-Shi Li Xin Li yong Li shang-lun Li Shuang-Ming Li Xiao-Gang Li Bao-Jun Li Pei-Wu Li Chun-Sheng Li Zhi-Jun Li Chang-luo Li Xiang-Min Li Yin-Ping Li Zong-Jun lu Zu-Xun lu Zhong-Qiu lu Zhi-Qian luo Xiao-Xing Liao Jian-Bo Lei Tao Ma Yu Ma Yue-Feng Ma qing-Bian Ma Lin-Hao Ma Jun-Qi Ma Shi-Nan Nie Jie-Miao Ou-Yang Peng Peng Qiao Pei Shu-Ming Pan Guo-Zhong qing Li-Jie Qin Wu-ying Qiao Fei Shao Wei Song Xing-Yue Song zhen-Ju Song Rong-Ju Sun De-Ya shang Du-Juan Sha Gui-Lan Tao Guo-Gang Tian ying-Ping Tian Jian-Guang Tian Chao-Yang Tong Zi-Ren Tang Meng-Xiong Tang Guo-Ping Wu Zhi Wan Tao Wang Xin Wang Peng Wang Zhong Wang Tong Wang Ri-Xing Wang Yi-Xin Wang Xiao-Dan Wang Ling Wu Wei Wei Hua Xiang Feng Xu Jun Xu Jie Xu Miao-Rong Xie Shuo-Gui Xu Tie Xu Feng Yu Wen Yi Li-shan Yang Shi-Jiao Yan Jin-Jian Yao Shou-Chun Yan xue-Zhong Yu Xian-Zhi Ye Xian-Liang Yan Fu-Bing Zhou Rong-Bin Zhou Ming Zhou Qiang Zhou Jin Zhou Ping Zhou Chang-Ju Zhu Hua-Dong Zhu Ji-Hong Zhu Hong Zhang Mao Zhang Hua Zhang Na Zhang Guo-Qiang Zhang Guo-Xiu Zhang Jin-Song Zhang Wen-Wu Zhang Wen-Zhong Zhang Jian-Feng Zhang Yi-Min Zhu Jun Zeng Yuan zheng Zhi-Jie zheng Shen Zhao Yan Zhao Min Zhao Bin Zhao Xiao-Dong Zhao Xiao-Jing Zhao Hong-Ke Zeng Sheng-Qiang Zou The Chinese Society of Emergency Medicine Research Unit of Island Emergency Medicine Chinese Academy of Medical SciencesHainan Medical University Key Laboratory of Emergency and Trauma of Ministry of Education Hainan Medical UniversityHaikouHainanChina Emergency and Trauma College Hainan Medical UniversityHaikouHainanChina Department of Emergency Hainan Clinical Research Center for Acute and Critical DiseasesThe Second Affiliated Hospital of Hainan Medical UniversityHaikouHainanChina Key Laboratory of Hainan Trauma and Disaster Rescue Key Laboratory of Trauma of Hainan Medical University

*** Sudden cardiac death(SCD)refers to sudden death due to a variety of cardiac *** is manifested as a sudden loss of consciousness,cardiac arrest,and respiratory arrest and generally shows early symptoms that are atypical and not easily detected[1].According to a recent study,nearly 544000 patients suffer from SCD every year in China[2].

关键词： cardiac death respiratory

新型冠状病毒肺炎药物预防、诊断、治疗与出院管理循证临床实践指南(更新版)

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

解放军医学杂志 2020年第10期45卷 1003-1031页

作者：靳英辉詹庆元彭志勇任学群尹训涛蔡林袁玉峰岳冀蓉张笑春杨启文纪建光夏剑李一荣周福祥高亚东余追徐峰涂明利谭力铭杨旻陈芳张晓菊曾玫朱渝刘新灿杨简赵东赤丁玉峰侯宁汪付兵陈昊张永刚李玮陈文施月仙杨秀芝王学军钟燕军赵明娟李柄辉马琳璐訾豪王娜王云云余绍福李路遥黄桥翁鸿任相颖罗丽莎范曼如黄笛薛竑飏余临心高锦萍邓通曾宪涛李宏军程真顺姚晓梅王行环无武汉大学中南医院循证与转化医学中心武汉430071 中日友好医院国家呼吸系统疾病临床研究中心北京100029 中日友好医院呼吸与危重症医学科北京100029 武汉雷神山医院武汉430200 武汉大学中南医院重症医学科武汉430071 河南大学循证医学与临床转化研究院河南开封475000 贵州省人民医院医学影像科贵阳550002 武汉大学中南医院骨科武汉430071 武汉大学中南医院肝胆外科武汉430071 四川大学华西医院国家老年疾病临床医学研究中心成都610041 四川大学华西医院老年医学中心成都610041 武汉大学中南医院医学影像中心武汉430071 中国医学科学院/北京协和医学院检验学系北京协和医院检验科北京100730 瑞典隆德大学临床研究中心/斯科讷大学医院马尔默25002 武汉大学中南医院急救中心武汉403371 武汉大学中南医院过敏反应科武汉403371 武汉大学中南医院肿瘤放化疗科武汉403371 武汉大学人民医院重症医学科武汉430060 山东大学齐鲁医院急诊科与胸痛中心济南250002 湖北医药学院附属随州市中心医院呼吸与重症医学科湖北随州441300 湖南省怀化市第二人民医院药学部湖南怀化418000 安徽医科大学第二附属医院重症医学科合肥230601 郑州大学医院内科郑州450001 河南省人民医院呼吸与危重症医学科郑州450003 复旦大学附属儿科医院感染传染科上海201102 四川大学华西第二医院感染科成都610041 河南中医药大学第一附属医院心内科郑州450000 三峡大学人民医院/宜昌市第一人民医院心内科湖北宜昌443000 武汉大学中南医院儿科武汉430071 华中科技大学同济医学院附属同济医院药学部武汉430030 山东第一医科大学附属省立医院/山东省立医院药学部济南250021 南京中医药大学教育部针药结合重点实验室南京210023 四川大学华西医院华西期刊社成都610041 青岛大学附属烟台毓璜顶医院检验医学中心山东烟台264000 十堰市太和医院(湖北医药学院附属医院)医学影像中心湖北十堰442000 北京大学护理学院北京100191 开封市中心医院呼吸与危重症医学科河南开封475000 北京电力医院急诊科北京100073 中南大学湘雅二医院重症医学科长沙410008 武汉大学中南医院泌尿科武汉430071 武汉大学中南医院血液科武汉430071 河南大学医学院护理与健康学院河南开封475000 山西医科大学护理学院太原030001 首都医科大学北京佑安医院放射诊断科北京100069 武汉大学中南医院呼吸与危重症医学科武汉430071 麦克马斯特大学卫生研究方法证据及影响系安大略省哈密尔顿市L8S 4L8加拿大中国医疗保健国际交流促进会循证医学分会中国研究型医院学会

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)导致的新型冠状病毒肺炎(COVID-19)自暴发以来迅速在全球蔓延,造成数以千万人感染及数十万患者死亡。基于研究证据的临床实践指南是诊治COVID-19的有力武器。在疫情早期阶段,该团队制定并发布... 详细信息

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)导致的新型冠状病毒肺炎(COVID-19)自暴发以来迅速在全球蔓延,造成数以千万人感染及数十万患者死亡。基于研究证据的临床实践指南是诊治COVID-19的有力武器。在疫情早期阶段,该团队制定并发布了《新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(标准版)》。疫情暴发后大量相关临床研究陆续开展并发表,新的证据可能会改变以前的推荐意见,更新指南的时机已经成熟。因此,该团队成立了由临床专家和方法学家组成的工作组,通过咨询一线临床专家提出并确定了与COVID-19管理相关的29个临床问题。通过系统检索有关COVID-19预防及诊疗的直接证据,使用GRADE方法评估证据质量并制订推荐意见,最终形成34条建议,其中6条强推荐,14条弱推荐,3条弱不推荐,11条为基于共识的建议;共涵盖4个方面,分别为药物预防,诊断(包括临床表现、RT-PCR检测、呼吸道标本、IgM和IgG抗体检测、CT检查、胸部X线片及无症状感染的CT特征),治疗方法[包括洛匹那韦-利托那韦、阿比朵尔、法匹拉韦、干扰素、瑞德西韦、抗病毒药的组合、羟氯喹/氯喹、白介素-6抑制剂、白介素-1抑制剂、糖皮质激素、清肺排毒汤、连花清瘟胶囊/颗粒、康复者血浆、肺移植、有创或无创通气、体外膜肺氧合支持(ECMO)]以及出院管理(包括复阳患者管理及出院标准)。此外,还制订了针对推荐意见的指南实施工具流程图,以期有力支持医护人员对COVID-19患者的照护。

关键词：新型冠状病毒肺炎 2019新型冠状病毒感染性疾病临床实践指南循证医学

超未成熟双胎儿临床救治结局及变化分析:一项广东省多中心回顾性研究

在线全文

学校读者我要写书评

暂无评论

中国当代儿科杂志 2022年第1期24卷 33-40页

作者：石碧君李颖吴繁冯周善崔其亮杨传忠叶晓彤戴怡蘅梁伟怡叶秀桢莫镜丁璐吴本清陈宏香黎炽旺张喆荣箫沈薇黄为民杨冰岩吕峻峰黄辉文霍乐颖饶红萍严文康任雪军杨勇王方方刘东刁诗光刘晓燕孟琼王玉王斌张丽娟黄宇戈敖当李伟中陈洁玲陈艳玲李薇陈志凤丁月琴李晓瑜黄越芳林霓阳蔡扬帆韩莎莎金雅柳国胜万忠和班奕白波李广洪严越秀超未成熟儿与超低出生体重儿研究协作组广州医科大学附属第三医院儿科广东广州510150 广东省深圳市妇幼保健院新生儿科广东深圳518028 广东省佛山市妇幼保健院新生儿科广东佛山528000 广东省妇幼保健院新生儿科广东广州510010 广东省深圳市人民医院新生儿科广东深圳518020 广东省梅州市人民医院新生儿科广东梅州514031 广州市妇女儿童医疗中心新生儿科广东广州510120 南方医科大学南方医院新生儿科广东广州510515 广东省中山市博爱医院新生儿科广东中山528400 广东省珠海市妇幼保健院新生儿科广东珠海519001 广东省惠州市中心人民医院新生儿科广东惠州516001 广东省东莞市妇幼保健院新生儿科广东东莞523002 广东省江门市中心医院儿科广东江门529000 广东省粤北人民医院新生儿科广东韶关512026 广东省第二人民医院儿科广东广州510317 南方医科大学珠江医院新生儿科广东广州510280 广东医科大学附属医院儿童医学中心广东湛江524001 汕头大学医学院第二附属医院儿科广东汕头515041 暨南大学医学院附属东莞医院儿科广东东莞523900 广东省东莞市人民医院儿科广东东莞523000 中山大学附属第一医院新生儿科广东广州510080 汕头大学医学院第一附属医院新生儿科广东汕头515041 暨南大学附属第一医院新生儿科广东广州510630 广东省佛山市南海区人民医院新生儿科广东佛山528200 广州市花都区人民医院新生儿科广东广州510800 广东省肇庆市第一人民医院儿科广东肇庆526020

目的探讨广东省超未成熟双胎儿临床救治结局及变化趋势。方法回顾性选择2008年1月至2017年12月广东省26家三级甲等医院新生儿科入院的胎龄<28周双胎儿269对,按照入院年份分为前5年组和后5年组,双胎中以出生体重高低分为重婴和轻婴。收... 详细信息

目的探讨广东省超未成熟双胎儿临床救治结局及变化趋势。方法回顾性选择2008年1月至2017年12月广东省26家三级甲等医院新生儿科入院的胎龄<28周双胎儿269对,按照入院年份分为前5年组和后5年组,双胎中以出生体重高低分为重婴和轻婴。收集孕母围生期和新生儿住院资料,分析前、后5年双胎儿存活率、并发症发生率的差异。结果后5年组超未成熟双胎儿、双胎中重婴、双胎中轻婴的重度窒息发生率、出生头围低于前5年组(P<0.05)。后5年组超未成熟双胎儿均死亡的比例低于前5年组,且后5年组双胎中重婴、双胎中轻婴的病死率低于前5年组(P<0.05)。后5年组双胎中重婴、双胎中轻婴肺出血、动脉导管未闭、脑室周围-脑室内出血、新生儿呼吸窘迫综合征的发生率均低于前5年组,支气管肺发育不良发生率高于前5年组(均P<0.05)。结论广东省26家三级甲等医院入院的胎龄<28周超未成熟双胎儿的存活率显著上升,且双胎内无论是重婴还是轻婴,发生重度窒息、肺出血、动脉导管未闭、脑室周围-脑室内出血、新生儿呼吸窘迫综合征的比例均明显下降,而发生支气管肺发育不良比例增加。伴随诊疗水平提升,未来需要由产前诊断、产科、新生儿科等组成多学科协作,共同制定科学的双胎妊娠管理策略。[中国当代儿科杂志,2022,24(1):33-40]

关键词：双胎儿病死率并发症出生体重超未成熟儿

维普期刊数据库博看期刊

CEPC Technical Design Report

在线全文

学校读者我要写书评

暂无评论

Radiation Detection Technology and Methods 2024年第1期8卷 I0003-I0016,1-1091页

作者： Waleed Abdallah Tiago Carlos Adorno de Freitas Konstantin Afanaciev Shakeel Ahmad Ijaz Ahmed Xiaocong Ai Abid Aleem Wolfgang Altmannshofer Fabio Alves Weiming An Rui An Daniele Paolo Anderle Stefan Antusch Yasuo Arai Andrej Arbuzov Abdesslam Arhrib Mustafa Ashry Sha Bai Yu Bai Yang Bai Vipul Bairathi Csaba Balazs Philip Bambade yong Ban Tripamo Bandyopadhyay Shou-shan Bao Desmond P.Barber Ayse Bat Varvara Batozskaya Subash Chandra Behera Alexander Belyaev Michele Bertucci Xiao-Jun Bi Yuanjie Bi Tianjian Bian Fabrizio Bianchi Thomas Biekotter Michela Biglietti Shalva Bilanishvili Deng Binglin Denis Bodrov Anton Bogomyagkov Serge Bondarenko Stewart Boogert Maarten Boonekamp Marcello Borri Angelo Bosotti Vincent Boudry Mohammed Boukidi Igor Boyko Ivanka Bozovic Giuseppe Bozzi Jean-Claude Brient Anastasiia Budzinskaya Masroor Bukhari Vladimir Bytev Giacomo Cacciapaglia Hua Cai Wenyong Cai Wujun Cai Yijian Cai Yizhou Cai Yuchen Cai Haiying Cai Huacheng Cai Lorenzo Calibbi Junsong Cang Guofu Cao Jianshe Cao Antoine Chance xuejun Chang Yue Chang Zhe Chang Xinyuan Chang Wei Chao Auttakit Chatrabhuti Yimin Che Yuzhi Che Bin Chen Danping Chen Fuqing Chen Fusan Chen Gang Chen Guoming Chen Hua-Xing Chen Huirun Chen Jinhui Chen Ji-Yuan Chen Kai Chen Mali Chen Mingjun Chen Mingshui Chen Ning Chen shanhong Chen shanzhen Chen Shao-Long Chen Shaomin Chen Shiqiang Chen Tianlu Chen Wei Chen Xiang Chen Xiaoyu Chen Xin Chen Xun Chen Xurong Chen Ye Chen ying Chen Yukai Chen Zelin Chen Zilin Chen Gang Chen Boping Chen Chunhui Chen Hok Chuen Cheng Huajie Cheng shan Cheng Tongguang Cheng Yunlong Chi Pietro Chimenti Wen Han Chiu Guk Cho Ming-Chung Chu Xiaotong Chu Ziliang Chu Guglielmo Coloretti Andreas Crivellin Hanhua Cui Xiaohao Cui Zhaoyuan Cui Brunella D'Anzi Ling-Yun Dai Xinchen Dai Xuwen Dai Antonio De Maria Nicola De Filippis Christophe De La Taille Francesca De Mori Chiara De Sio Elisa Del Core Shuangxue Deng Wei-Tian Deng Zhi Deng Ziyan Deng Bhupal Dev Tang Dewen Biagio Di Micco Ran ding Siqin dingl Yadong ding Haiyi Dong Jianin AGH University of Science and Technology Faculty of Physics and Applied Computer ScienceKrakow Anhui University HefeiAnhui Applied Physics Department Federal Urdu University of ArtsScience and TechnologyIslamabad Banaras Hindu University Institute of ScienceVaranasi Bandirma Onyedi Eylul University Bandirma Beihang University Beijing Beijing Computational Science Research Center Beijing Beijing Conveyi LTD Beijing Beijing Glass Research Institute Co. LtdBeijing Beijing Institute of Technology Beijing Beijing Normal University Beijing Brown University ProvidenceRI Budker Institute of Nuclear Physics Novosibirsk Cadi Ayyad University Laboratory of Fundamental and Applied PhysicsPolydisciplinary FacultyMarrakech Cairo University Giza Center for Theory and Computation National Tsing Hua UniversityHsinchu Central China Normal University WuhanHubei Central South University ChangshaHunan Centro de Fisica Teorica de Particulas Universidade Tecnica de LisboaLisboa Chengdu KaitengSifang Digital Radio&TV Equipment Co. LtdChengduSichuan China academy of engineering physics MianyangSichuan China building materials academy Beijing China Center of Advanced Science and Technology Beijing China Institute of Atomic Energy Beijing China Jiliang University HangzhouZhejiang China Nuclear Instrument CO. LTDBeijing China University of Geosciences Beijing China University of Geosciences WuhanHubei China University of Mining and Technology XuzhouJiangsu China West Normal University NanchongSichuan Chongqing University Department of PhysicsChongqing Chulalongkorn University Bangkok City University of Hong Kong Department of PhysicsHong Kong Cockcroft Institute Daresbury Cornell University IthacaNY CPPM(AMU/IPhU&CNRS/INP) Marseille Dalian Minzu University DalianLiaoning Dalian University of Technology Department of PhysicsDalian Deutsches Elektronen-Synchrotron DESY Hamburg Dzhelepov Laboratory of Nuclear Problems of Joint Institute for Nuclear Research(DLNP JINR) Dubna East China University Of Science And Technol

The Circular Electron Positron Collider(CEPC)is a large scientific project initiated and hosted by China,fostered through extensive collaboration with international *** complex comprises four accelerators:a 30 GeV Linac,a 1.1 GeV Damping Ring,a Booster capable of achieving energies up to 180 GeV,and a Collider operating at varying energy modes(Z,W,H,and tt).The Linac and Damping Ring are situated on the surface,while the subterranean Booster and Collider are housed in a 100 km circumference underground tunnel,strategically accommodating future expansion with provisions for a potential Super Proton Proton Collider(SPPC).The CEPC primarily serves as a Higgs *** its baseline design with synchrotron radiation(SR)power of 30 MW per beam,it can achieve a luminosity of 5×10^(34)cm^(-2)s^(-1)per interaction point(IP),resulting in an integrated luminosity of 13 ab^(-1)for two IPs over a decade,producing 2.6 million Higgs *** the SR power to 50 MW per beam expands the CEPC's capability to generate 4.3 million Higgs bosons,facilitating precise measurements of Higgs coupling at sub-percent levels,exceeding the precision expected from the HL-LHC by an order of *** Technical Design Report(TDR)follows the Preliminary Conceptual Design Report(Pre-CDR,2015)and the Conceptual Design Report(CDR,2018),comprehensively detailing the machine's layout,performance metrics,physical design and analysis,technical systems design,R&D and prototyping efforts,and associated civil engineering ***,it includes a cost estimate and a preliminary construction timeline,establishing a framework for forthcoming engineering design phase and site selection *** is anticipated to begin around 2027-2028,pending government approval,with an estimated duration of 8 *** commencement of experiments and data collection could potentially be initiated in the mid-2030s.

关键词： initiated exceeding precise

中国14家医院超/极早产儿早期预后的多中心调查

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

中国医刊 2018年第12期53卷 1356-1362页

作者：孔祥永张珊封志纯徐凤丹童笑梅刘少君刘子源吕红艳杨李红吴素静巨容汪瑾彭立赵小林郭金珍李占魁曾淑娟丘惠娴温伟溪武辉李莹李楠贾文峥张雪峰郭果刘卫鹏王凤李改梅刘芳李薇赵晓英程红斌许云波陈文超尹欢丁艳洁王晓亮单瑞艳许平韩梅盈杨春燕陈铁强张路叶春华儿童器官功能衰竭北京市重点实验室陆军总医院附属八一儿童医院新生儿科北京100700 南方医科大学陆军总医院临床医学院北京100700 出生缺陷防控关键技术国家工程实验室北京100000 广东医学院广东东莞523808 北京大学第三医院新生儿科北京100191 邯郸市妇幼保健院新生儿科河北邯郸056001 成都市妇女儿童中心医院新生儿科四川成都610091 西北妇女儿童医院新生儿科陕西西安710003 深圳市龙岗中心医院儿科广东深圳518116 吉林大学第一医院儿科吉林长春130021 解放军第302医院新生儿科北京100039 海军总医院儿科北京100048 白求恩国际和平医院儿科河北石家庄050000 黄石市妇幼保健院儿科湖北黄石435003 烟台毓璜顶医院儿科山东烟台264000 聊城市人民医院儿科山东聊城252004 长沙妇幼保健院新生儿科湖南长沙410007

目的报道国内14家医院产科收治的出生胎龄24～31周早产儿的早期病死率和主要并发症发生率,并分析其影响因素。方法收集2013年1月1日至2014年12月31日国内14家医院产科收治的出生胎龄24～31周早产儿的一般资料,分析各胎龄组早产儿的病死... 详细信息

目的报道国内14家医院产科收治的出生胎龄24～31周早产儿的早期病死率和主要并发症发生率,并分析其影响因素。方法收集2013年1月1日至2014年12月31日国内14家医院产科收治的出生胎龄24～31周早产儿的一般资料,分析各胎龄组早产儿的病死率和主要并发症如支气管肺发育不良(bronchopulmonary dysplasia,BPD)、新生儿坏死性小肠结肠炎(necrotizing enterocolitis,NEC)、早产儿视网膜病(retinopathy of prematurity,ROP)、脑室内出血(intraventricular hemorrhage,IVH)和败血症等的发生率,并分析其影响因素。结果 24～31周各胎龄组早产儿的存活率分别为0、28.0%、84.8%、83.5%、87.4%、90.7%、93.9%和96.0%,无严重合并症存活率分别为0、8.0%、60.6%、53.2%、62.3%、67.9%、79.1%和85.8%,随着胎龄的增加存活率及无严重合并症存活率均增加。胎龄<28周早产儿的产前激素使用率低于28～31周(28.0%～44.3%vs 49.7%～59.6%,P<0.05),总体使用率为56.0%,足疗程为32.3%。早产儿胎龄越小,并发症发生率越高。24～31周早产儿总体呼吸窘迫综合征的发生率为58.5%, BPD的发生率为12.5%,NEC的发生率为3.9%,IVH的发生率为15.4%,ROP的发生率为5.4%,动脉导管未闭的发生率为28.4%,败血症的发生率为9.7%。低胎龄(OR=0.891,95%CI:0.796～0.999,P=0.0047)、低出生体重(OR=0.520,95%CI:0.420～0.643,P=0.000)、小于胎龄儿(OR=1.861,95%CI:1.148～3.017,P=0.012)和5分钟低Apgar评分(OR=1.947,95%CI:1.269～2.987,P=0.002)是早产儿死亡的高危因素。低胎龄(OR=0.666,95%CI:0.645～0.688,P=0.000)、低出生体重(OR=0.921,95%CI:0.851～0.997,P=0.041)、男性(OR=1.235,95%CI:1.132～1.347,P=0.000)、小于胎龄儿(OR=1.511,95%CI:1.300～1.755,P=0.000)、5分钟时低Apgar评分(OR=2.262,95%CI:1.950～2.624,P=0.000)以及围产期合并症如前置胎盘(OR=1.452,95%CI:1.202～1.753,P=0.000)、胎盘早剥(OR=1.380,95%CI:1.082～1.760,P=0.010)、妊娠期高血压疾病(OR=2.262,95%CI:1.950～2.624,P=0.000)、多胎(OR=1.162,95%CI:1.056～1.278,P=0.002)和产前发热(OR=1.367,95%CI:1.228～1.521,P=0.000)等是早产儿并发症发生的高危因素。产前使用激素治疗可以降低超早产儿和极早产儿的死亡风险(OR=0.615,95%CI:0.483～0.801,P=0.033)。结论胎龄26周以下超早产儿的存活率较低,26～31周早产儿的存活率虽逐渐接近发达国家,但严重并发症的发生率较高,提高对围产期合并症的预防和管理有助于改善此类早产儿的生存质量。

关键词：超早产儿极早产儿预后